Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Rosenthal

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
British Journal of Pharmacology|May 1, 1977
Development of nicotinic responses in the rat adrenal medulla and long-term effects of neonatal nicotine administrationR N Rosenthal, T A Slotkin
Postgraduate Medicine|April 1, 1995
Physical examination of substance abusers. How to gather evidence of concealed problemsL M Westreich, R N Rosenthal
Schizophrenia Bulletin|January 1, 1997
Differential diagnosis of substance-induced psychosis and schizophrenia in patients with substance use disordersR N Rosenthal, C R Miner
Psychosomatics|July 17, 1998
Transient psychosis with psychogenic polydipsia in schizotypal patient taking fluoxetineZ Gutkovich, R N Rosenthal, L Bogdonoff
The Journal of Clinical Psychiatry|February 1, 1995
Methadone withdrawal psychosisI Levinson, I I Galynker, R N Rosenthal
Comprehensive Psychiatry|March 1, 1994
Positive and negative syndrome typology in schizophrenic patients with psychoactive substance use disordersR N Rosenthal, D J Hellerstein, C R Miner
The Psychiatric Quarterly|January 1, 1992
Integrated services for treatment of schizophrenic substance abusers: demographics, symptoms, and substance abuse patternsR N Rosenthal, D J Hellerstein, C R Miner
The Psychiatric Quarterly|August 30, 2001
Integrating services for schizophrenia and substance abuseD J Hellerstein, R N Rosenthal, C R Miner
The Journal of Clinical Psychiatry|March 1, 1995
Doxepin withdrawal maniaI I Galynker, R N Rosenthal, C Perkel, et al.
The Journal of Psychotherapy Practice and Research|June 16, 2012
Supportive therapy as the treatment model of choiceD J Hellerstein, H Pinsker, R N Rosenthal, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
British Journal of Pharmacology|May 1, 1977
Development of nicotinic responses in the rat adrenal medulla and long-term effects of neonatal nicotine administrationR N Rosenthal, T A Slotkin
Postgraduate Medicine|April 1, 1995
Physical examination of substance abusers. How to gather evidence of concealed problemsL M Westreich, R N Rosenthal
Schizophrenia Bulletin|January 1, 1997
Differential diagnosis of substance-induced psychosis and schizophrenia in patients with substance use disordersR N Rosenthal, C R Miner
Psychosomatics|July 17, 1998
Transient psychosis with psychogenic polydipsia in schizotypal patient taking fluoxetineZ Gutkovich, R N Rosenthal, L Bogdonoff
The Journal of Clinical Psychiatry|February 1, 1995
Methadone withdrawal psychosisI Levinson, I I Galynker, R N Rosenthal
Comprehensive Psychiatry|March 1, 1994
Positive and negative syndrome typology in schizophrenic patients with psychoactive substance use disordersR N Rosenthal, D J Hellerstein, C R Miner
The Psychiatric Quarterly|January 1, 1992
Integrated services for treatment of schizophrenic substance abusers: demographics, symptoms, and substance abuse patternsR N Rosenthal, D J Hellerstein, C R Miner
The Psychiatric Quarterly|August 30, 2001
Integrating services for schizophrenia and substance abuseD J Hellerstein, R N Rosenthal, C R Miner
The Journal of Clinical Psychiatry|March 1, 1995
Doxepin withdrawal maniaI I Galynker, R N Rosenthal, C Perkel, et al.
The Journal of Psychotherapy Practice and Research|June 16, 2012
Supportive therapy as the treatment model of choiceD J Hellerstein, H Pinsker, R N Rosenthal, et al.
Pageof 3